Multiple Sclerosis

A new study found that smoking may increase the odds of a diagnosis of multiple sclerosis, and high alcohol consumption may be associated with more severe neurodegeneration.

A new review describes the effects of immunotherapy on immune response to vaccination in patients with neuroimmunologic disease.

A new review describes the important role of the general practitioner in cognitive screening of multiple sclerosis patients and the best screening tools available.

A national strategy of early initiation of highly effective disease-modifying therapy was associated with improved outcomes in patients with relapsing-remitting multiple sclerosis compared with an escalation strategy, according to a recent study.

On March 19, 2021, Janssen Pharmaceutical Companies announced that the US Food and Drug Administration approved ponesimod for the treatment of relapsing multiple sclerosis in adults. The approval indications include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

Researchers found that depression increased the risk of vascular disease and all-cause mortality in patients with multiple sclerosis, according to a recent study.

The trajectory of results on at-home computerized tests for cognition may identify patients at risk for disability progression due to relapsing-remitting multiple sclerosis, according to a recent study.

Black patients with multiple sclerosis had greater disease severity than white patients after adjusting for socioeconomic status, according to a recent study in the United States.

Patients with multiple sclerosis who were recently treated with anti-CD20 monoclonal antibody therapies had reduced antibody and B-cell responses but intact T-cell responses to SARS-CoV-2 mRNA vaccination compared with healthy people.